245 related articles for article (PubMed ID: 19244160)
1. Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant.
Mosnier LO; Zampolli A; Kerschen EJ; Schuepbach RA; Banerjee Y; Fernández JA; Yang XV; Riewald M; Weiler H; Ruggeri ZM; Griffin JH
Blood; 2009 Jun; 113(23):5970-8. PubMed ID: 19244160
[TBL] [Abstract][Full Text] [Related]
2. Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions.
Mosnier LO; Yang XV; Griffin JH
J Biol Chem; 2007 Nov; 282(45):33022-33. PubMed ID: 17872949
[TBL] [Abstract][Full Text] [Related]
3. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C.
Kerschen EJ; Fernandez JA; Cooley BC; Yang XV; Sood R; Mosnier LO; Castellino FJ; Mackman N; Griffin JH; Weiler H
J Exp Med; 2007 Oct; 204(10):2439-48. PubMed ID: 17893198
[TBL] [Abstract][Full Text] [Related]
4. Activated protein C.
Griffin JH; Fernández JA; Gale AJ; Mosnier LO
J Thromb Haemost; 2007 Jul; 5 Suppl 1():73-80. PubMed ID: 17635713
[TBL] [Abstract][Full Text] [Related]
5. The cytoprotective protein C pathway.
Mosnier LO; Zlokovic BV; Griffin JH
Blood; 2007 Apr; 109(8):3161-72. PubMed ID: 17110453
[TBL] [Abstract][Full Text] [Related]
6. C-terminal residues of activated protein C light chain contribute to its anticoagulant and cytoprotective activities.
Yamashita A; Zhang Y; Sanner MF; Griffin JH; Mosnier LO
J Thromb Haemost; 2020 May; 18(5):1027-1038. PubMed ID: 32017367
[TBL] [Abstract][Full Text] [Related]
7. Activated protein C variants with normal cytoprotective but reduced anticoagulant activity.
Mosnier LO; Gale AJ; Yegneswaran S; Griffin JH
Blood; 2004 Sep; 104(6):1740-4. PubMed ID: 15178575
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C: biased for translation.
Griffin JH; Zlokovic BV; Mosnier LO
Blood; 2015 May; 125(19):2898-907. PubMed ID: 25824691
[TBL] [Abstract][Full Text] [Related]
9. Protein C anticoagulant and cytoprotective pathways.
Griffin JH; Zlokovic BV; Mosnier LO
Int J Hematol; 2012 Apr; 95(4):333-45. PubMed ID: 22477541
[TBL] [Abstract][Full Text] [Related]
10. An orthosteric/allosteric bivalent peptide agonist comprising covalently linked protease-activated receptor-derived peptides mimics in vitro and in vivo activities of activated protein C.
Healy LD; Fernández JA; Aiolfi R; Mosnier LO; Griffin JH
J Thromb Haemost; 2024 Jul; 22(7):2039-2051. PubMed ID: 38670314
[TBL] [Abstract][Full Text] [Related]
11. Activated protein C, protease activated receptor 1, and neuroprotection.
Griffin JH; Zlokovic BV; Mosnier LO
Blood; 2018 Jul; 132(2):159-169. PubMed ID: 29866816
[TBL] [Abstract][Full Text] [Related]
12. Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.
Mosnier LO; Sinha RK; Burnier L; Bouwens EA; Griffin JH
Blood; 2012 Dec; 120(26):5237-46. PubMed ID: 23149848
[TBL] [Abstract][Full Text] [Related]
13. Cytoprotective-selective activated protein C attenuates Pseudomonas aeruginosa-induced lung injury in mice.
Bir N; Lafargue M; Howard M; Goolaerts A; Roux J; Carles M; Cohen MJ; Iles KE; Fernández JA; Griffin JH; Pittet JF
Am J Respir Cell Mol Biol; 2011 Sep; 45(3):632-41. PubMed ID: 21257925
[TBL] [Abstract][Full Text] [Related]
14. Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1.
Yang L; Bae JS; Manithody C; Rezaie AR
J Biol Chem; 2007 Aug; 282(35):25493-500. PubMed ID: 17580306
[TBL] [Abstract][Full Text] [Related]
15. Novel mechanisms for activated protein C cytoprotective activities involving noncanonical activation of protease-activated receptor 3.
Burnier L; Mosnier LO
Blood; 2013 Aug; 122(5):807-16. PubMed ID: 23788139
[TBL] [Abstract][Full Text] [Related]
16. Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity.
Wang Y; Thiyagarajan M; Chow N; Singh I; Guo H; Davis TP; Zlokovic BV
Stroke; 2009 May; 40(5):1864-9. PubMed ID: 19057019
[TBL] [Abstract][Full Text] [Related]
17. Protective mechanisms of activated protein C in severe inflammatory disorders.
Neyrinck AP; Liu KD; Howard JP; Matthay MA
Br J Pharmacol; 2009 Oct; 158(4):1034-47. PubMed ID: 19466992
[TBL] [Abstract][Full Text] [Related]
18. 2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: Thrombotic Stroke: Neuroprotective Therapy by Recombinant-Activated Protein C.
Griffin JH; Mosnier LO; Fernández JA; Zlokovic BV
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2143-2151. PubMed ID: 27758767
[TBL] [Abstract][Full Text] [Related]
19. An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C.
von Drygalski A; Bhat V; Gale AJ; Burnier L; Cramer TJ; Griffin JH; Mosnier LO
PLoS One; 2014; 9(8):e104304. PubMed ID: 25127130
[TBL] [Abstract][Full Text] [Related]
20. Activated protein C N-linked glycans modulate cytoprotective signaling function on endothelial cells.
Ní Ainle F; O'Donnell JS; Johnson JA; Brown L; Gleeson EM; Smith OP; Preston RJ
J Biol Chem; 2011 Jan; 286(2):1323-30. PubMed ID: 21044954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
